Please login to the form below

Not currently logged in
Email:
Password:

Reig Jofre boosts Forté Pharma’s senior team

Appoints Alain Boutboul as the nutritional supplements group’s general manager

Alain BoutboulReig Jofre’s nutritional supplement group Forté Pharma has appointed a new general manager in the form of Alain Boutboul.

Boutboul joined Forté Pharma as one of its reference shareholders and Reig Jofre said the “reincorporation of Boutboul at the head of Forté Pharma is conducted in parallel to the signing of business alliance with Santarome for its development in the pharmacy channel”.

Boutboul will head Forté’s new strategic plan, which consists of the development of new products based on chronobiology and in synergistic combinations of ingredients with technically and scientifically proven results.

He will also oversee the launch of a new promotional advertising model.

Ignasi Biosca, chief executive officer, Reig Jofre, said: “We had been working for some time on Forté Pharma's development plan after the merger with Natraceutical, and I am convinced that the leadership of Alain Boutboul, the introduction in pharmacies of the new brand Santarome and Forté Pharma’s new strategic plan in line with the strategy of Reig Jofre, will mark a turning point in the development of Forté Pharma.”

22nd November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics